Anika to Issue Third Quarter 2026 Financial Results on Friday, November 6, 2026GlobeNewsWire · 2 days ago
Is Anika Therapeutics (ANIK) Outperforming Other Medical Stocks This Year?Zacks Investment Research · Sep 25, 2026
Xencor (NASDAQ:XNCR) versus Anika Therapeutics (NASDAQ:ANIK) Head-To-Head ContrastDefense World · Sep 18, 2026
Corient Private Wealth LP Takes Position in Anika Therapeutics Inc. $ANIKDefense World · Sep 8, 2026
Hsbc Holdings PLC Invests $727,000 in Anika Therapeutics Inc. $ANIKDefense World · Sep 2, 2026
Best Momentum Stocks to Buy for August 26thZacks Investment Research · Aug 26, 2026Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core focus areas include osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and advanced bone-preserving joint technologies. All of Anika's products are developed, manufactured, and commercialized utilizing their proprietary hyaluronic acid (HA) technology platform.
| Date | Est. | Actual | |
|---|---|---|---|
| Jul 29, 2026 | $0.03 | $0.42 | Beat |
| Apr 29, 2026 | -$0.07 | $0.27 | Beat |
| Feb 26, 2026 | -$0.13 | $0.31 | Beat |
| Nov 5, 2025 | $0.02 | $0.04 | Beat |
| Jul 30, 2025 | -$0.13 | -$0.13 | Beat |
| May 9, 2025 | $0.09 | -$0.06 | Miss |